MA

Mahtab Alam Ansari

Director Director DIN 08360659
DIN 08360659 First appointment Feb 2019 Primary industry Trading
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Feb 2019
Shareholding value β€’β€’β€’β€’ Premium profile

About Mahtab Alam Ansari

Data last updated:

Mahtab Alam Ansari was a Director at Winalex Pharma Private Limited (2022–2023) and Director at Elliotts Pharmaceuticals Private Limited (from 2019). The companies operate in Trading.

DIN 08360659
Primary Designation Director
Industry Trading
First Appointment 13 Feb 2019
Oldest Company Age 7 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Winalex Pharma Private Limited U51909UP2022PTC170311
Director07 Sep 20222022Active
Director13 Feb 20192019Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Elliotts Pharmaceuticals Private Limited
Winalex Pharma Private Limited
Premium access

Shareholding and investment profile for Mahtab Alam Ansari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mahtab Alam Ansari

Mahtab Alam Ansari was first appointed on 13 Feb 2019 as Director at Elliotts Pharmaceuticals Private Limited. The most recent appointment on record is 07 Sep 2022 at Winalex Pharma Private Limited.

Mahtab Alam Ansari held 2 earlier board appointments: Winalex Pharma Private Limited (Director, 07 Sep 2022 to 01 Dec 2023); Elliotts Pharmaceuticals Private Limited (Director, from 13 Feb 2019).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available